Results 21 to 30 of about 218,733 (303)

Hyperuricemia is a risk factor for the onset of impaired fasting glucose in men with a high plasma glucose level: a community-based study.

PLoS ONE, 2014
BackgroundIt is not clear whether elevated uric acid is a risk factor for the onset of impaired fasting glucose after stratifying by baseline fasting plasma glucose levels. We conducted a community-based retrospective longitudinal cohort study to clarify
Teruki Miyake, Teru Kumagi, Shinya Furukawa, Masashi Hirooka, Keitarou Kawasaki, Mitsuhito Koizumi, Yasuhiko Todo, Shin Yamamoto, Masanori Abe, Kohichiro Kitai, Bunzo Matsuura, Yoichi Hiasa   +11 more
doaj   +1 more source

Effect of Atorvastatin on Glycaemic Parameters in Normoglycaemic and Prediabetic Subjects: A Prospective, Panel Study [PDF]

Journal of Clinical and Diagnostic Research, 2017
Introduction: Type 2 diabetes is associated with obesity and dyslipidemia, which are risk factor for cardiovascular disease. With recent FDA approved indications for statins being widened because of its lipid lowering and pleiotropic effects, statins ...
Sansita Parida, Trupti Rekha Swain, Satya Narayan Routray, Rituparna Maiti   +3 more
doaj   +1 more source

Different Mechanisms for Impaired Fasting Glucose and Impaired Postprandial Glucose Tolerance in Humans [PDF]

Diabetes Care, 2006
OBJECTIVE—To compare the pathophysiology of impaired fasting glucose (IFG) and impaired glucose tolerance (IGT) in a more comprehensive and standardized fashion than has hitherto been done. RESEARCH DESIGN AND METHODS—We studied 21 individuals with isolated IFG (IFG/normal glucose tolerance [NGT]), 61 individuals with isolated IGT ...
Meyer, Christian, Pimenta, Walkyria, Woerle, Hans J., Van Haeften, Timon, Szoke, Ervin, Mitrakou, Asimina, Gerich, John   +6 more
openaire   +4 more sources

Insulin-like growth factor-1 is a negative modulator of glucagon secretion [PDF]

, 2017
Glucagon secretion involves a combination of paracrine, autocrine, hormonal, and autonomic neural mechanisms. Type 2 diabetes often presents impaired glucagon suppression by insulin and glucose.
Andreozzi, F, Di Fatta, C, Fuoco, A, Mancuso, E, Mannino, Gc, Sesti, G, Spiga, R   +6 more
core   +1 more source

Impaired Glucose Tolerance and Impaired Fasting Glucose Share Similar Underlying Pathophysiologies

The Tohoku Journal of Experimental Medicine, 2007
Both impaired glucose tolerance (IGT) and impaired fasting glucose (IFG) are pre-diabetic states. IGT was defined as having normal fasting plasma glucose (< 6.1 mmol/l) and abnormal 2-hr post-challenge plasma glucose. IFG was defined as having abnormal fasting plasma and normal 2-hr post-challenge plasma glucose (< 7.8 mmol/l). To explore whether these
Jiunn Diann, Lin, Hsiang-Lin, Wan, Jer-Chuan, Li, Chung-Ze, Wu, Shi-Wen, Kuo, Chang-Hsun, Hsieh, Wei-Chen, Lian, Chien-Hsing, Lee, Mei-Teng, Kao, Dee, Pei   +9 more
openaire   +3 more sources

Correlation between non-diabetic fasting blood glucose levels and 2-h post loading blood sugar levels with waist-to-height ratio in rural population of Malwa region of Central India

National Journal of Physiology, Pharmacy and Pharmacology, 2020
Background: Prediabetes is a stage of glucose tolerance between normal glucose tolerance and diabetes and is characterized by impaired fasting glucose (IFG) and impaired glucose tolerance (IGT).
Abhilasha Dutta, Abhishek Kumar, Sarbil Kumari   +2 more
doaj   +1 more source

Impaired fasting glucose levels among perinatally HIV-infected adolescents and youths in Dar es Salaam, Tanzania

Frontiers in Endocrinology, 2022
ObjectiveThis study assessed impaired fasting glucose and associated factors among perinatally HIV-infected adolescents and youths in Dar es salaam Tanzania.BackgroundImpaired fasting glucose is a marker of heightened risk for developing type 2 diabetes ...
Lilian Nkinda, Eliud Buberwa, Peter Memiah, Alieth Ntagalinda, Martin George, Frank Msafiri, Agricola Joachim, Mtebe Majigo, Kaushik Ramaiya, Bruno Sunguya   +9 more
doaj   +1 more source

Prevalence of metabolic syndrome (MetS) in Chinese subjects gradually increased with impaired glucose homeostasis: a multicenter, clinical based, cross-sectional study

BMC Public Health, 2012
Background Metabolic Syndrome (MetS) is a high risk factor for Cardiovascular Diseases (CVD). We estimated to investigate how MetS prevalence by glucose homeostasis varies across different age and gender groups.
Xiang Yufei, Huang Gan, Zhou Weidong, Che Zhihong, Zhou Pengcheng, Zhou Zhiguang   +5 more
doaj   +1 more source

Impaired fasting glucose in breast cancer survivors of a general hospital at Mexico City: A case series study

Journal of Research in Medical Sciences, 2019
Background: According to an Anglo-Saxon study, in breast cancer survivors, there is a high prevalence of impaired fasting glucose. Our aim was to assess the impaired fasting glucose occurring in Mexican woman survivors of breast cancer.
Carlos Manuel Ortiz-Mendoza
doaj   +1 more source

Non-altered incretin secretion in women with impaired fasting plasma glucose in the early stage of pregnancy: a case control study

Diabetology & Metabolic Syndrome, 2023
Backgrounds Glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic peptide (GIP) may be involved in pathogenesis of gestational diabetes mellitus (GDM).
Ondrej Krystynik, David Karasek, Michal Kahle, Veronika Kubickova, Dominika Macakova, Lubica Cibickova, Milos Mraz, Martin Haluzik   +7 more
doaj   +1 more source